Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aljoeson Walker

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Neurology and Therapy|October 27, 2019
Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study)Annette F Okai, Lilyana Amezcua, Regina R Berkovich, et al.
Neurology|February 20, 2025
Real-world Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates (P4-6.005)Sophia Woodson, Edward Gettings, Chu-Yueh Guo, et al.
Neurology and Therapy|June 16, 2025
Comparative Effectiveness of Fumarates Versus Sphingosine-1-Phosphate Receptor Modulators in Black Patients with Multiple SclerosisSophia Woodson, Edward J Gettings, Chu-Yueh Guo, et al.
Neurology and Therapy|June 16, 2025
Real-World Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates in the USASophia Woodson, Edward J Gettings, Chu-Yueh Guo, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Neurology and Therapy|October 27, 2019
Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study)Annette F Okai, Lilyana Amezcua, Regina R Berkovich, et al.
Neurology|February 20, 2025
Real-world Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates (P4-6.005)Sophia Woodson, Edward Gettings, Chu-Yueh Guo, et al.
Neurology and Therapy|June 16, 2025
Comparative Effectiveness of Fumarates Versus Sphingosine-1-Phosphate Receptor Modulators in Black Patients with Multiple SclerosisSophia Woodson, Edward J Gettings, Chu-Yueh Guo, et al.
Neurology and Therapy|June 16, 2025
Real-World Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates in the USASophia Woodson, Edward J Gettings, Chu-Yueh Guo, et al.
Pageof 2